Intestinal Parasitic Infection in Type II Diabetic Patients Correlated with COVID-19: A Case-Control Study

Abeer Omer Ahmed; Abeer Abbas Ali

doi:10.56286/51sh5f24

Authors

Abeer Omer Ahmed Kirkuk Directorate of Health, Ministry of Health, Kirkuk 36001, Iraq
Abeer Abbas Ali Department of Medical Laboratory Techniques, College of Health and Medical Techniques, Northern Technical University, Kirkuk 36001, Iraq https://orcid.org/0000-0002-4274-5209

DOI:

https://doi.org/10.56286/51sh5f24

Keywords:

Intestinal Parasites, Type II Diabetes Mellitus, COVID-19

Abstract

Intestinal parasites are a collection of infectious disorders continue to pose a serious threat to public health in Type-2 diabetes mellitus (T2DM) which is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARSCoV-2. Determine the effect of COVID-19 on the infection with intestinal parasites in Type II diabetic patients. The current study is conducted on 135, 72 diabetic patients infected with intestinal parasites with previous infection with COVID-19 (38 males and 34 females) and 63 diabetic patients without any another infection (32 male and 31 female) served as control aged (25-75 years) diagnosed by consultant physician, according to the laboratory diagnosis (HbA1c), from (November 2021 to March 2022). (63 of 66 diabetic patients) were infected with COVID-19 with percentage of (95.454%). Most diabetic patients infected with intestinal parasites were infected in the past with COVID19.

Downloads

Download data is not yet available.

References

Omrani VF, Fallahi S, Rostami A, Siyadatpanah A, Barzgarpour G, Mehravar S, et al. Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection [Internet]. 2015;43(5):537–44. Available from: http://dx.doi.org/10.1007/s15010-015-0778-6

Rey-Reñones C, Martinez-Torres S, Martín-Luján FM, Pericas C, Redondo A, VilaplanaCarnerero C, et al. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Biomedicines. 2022;10(9):1–12.

Salamandane C, Lobo ML, Afonso S, Miambo R, Matos O. Occurrence of intestinal parasites of public health significance in fresh horticultural products sold in maputo markets and supermarkets, mozambique. Microorganisms. 2021;9(9).

Barsoum, Rashad. (2005). Parasitic infections in organ transplantation. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2. 258-67.

Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12(1):62–6.

Deutsch AJ, Ahlqvist E, Udler MS. Phenotypic and genetic classification of diabetes. Diabetologia. 2022;1758–69.

Peric S, Stulnig TM. Diabetes and COVID-19 Disease — Management — People. 2020;356–61.

Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, et al. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab Syndr Clin Res Rev [Internet]. 2021;15(6):102268. Available from: https://doi.org/10.1016/j.dsx.2021.102268

Galani IE, Andreakos E. Neutrophils in viral infections: Current concepts and caveats. J Leukoc Biol. 2015;98(4):557–64.

Sarkari B, Hosseini G, Motazedian MH, Fararouei M, Moshfe A. Prevalence and risk factors of intestinal protozoan infections: A population-based study in rural areas of Boyer-Ahmad district, Southwestern Iran. BMC Infect Dis [Internet]. 2016;16(1):1–5. Available from: http://dx.doi.org/10.1186/s12879-016-2047-4

Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R. A contemporary review on pathogenesis and immunity of COVID 19 infection. Mol Biol Rep [Internet]. 2020;47(7):5365–76. Available from: https://doi.org/10.1007/s11033-020-05621-1

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

Pranata R, Henrina J, Matthew W, Lawrensia S, Huang I. Diabetes and COVID-19 : The past , the present , and the future. Metabolism [Internet]. 2021;121:154814. Available from: https://doi.org/10.1016/j.metabol.2021.154814

Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):1–13.

Bernin H, Lotter H. Sex bias in the outcome of human tropical infectious diseases: Influence of steroid hormones. J Infect Dis. 2014;209(SUPPL. 3).

Rijal B, Oda Y, Basnet R, Rijal B, Parajuli K, Gurung CK, et al. Gender variations in the prevalence of parasitic infections and the level of awareness in adolescents in rural Nepal. Vol. 32, Southeast Asian Journal of Tropical Medicine and Public Health. 2001. p. 575– 80.